Jeff Geschwind, MD – Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD, focuses on targeting cancer metabolism to develop novel drugs. His research on glycolysis inhibition provides new strategies to combat aggressive tumors. https://www.linkedin.com/in/jeff-geschwind-037200174